Literature DB >> 2562897

Treatment of essential thrombocythaemia with interferon alpha-2b.

D May, U B Wandl, N Niederle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2562897     DOI： 10.1016/s0140-6736(89)91446-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia.

Authors:  M J Abegg-Werter; J M Raemaekers; B E de Pauw; C Haanen
Journal:  Blut       Date:  1990-01

2.  Interferon alpha-2b in the long-term treatment of essential thrombocythemia.

Authors:  S Sacchi; A Tabilio; P Leoni; A Riccardi; A Vecchi; C Messora; F Falzetti; S Rupoli; G Ucci; M F Martelli
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

3.  Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.

Authors:  M Nagel-Hiemke; C Hiemke; G Kummer; T Moritz; H Müller; S Seeber; N Niederle
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.